Three days of stimulating discussions, new and renewed connections and significant announcements marked World Cancer Congress 2022 in Geneva.
ATOM Coalition partners Medicines Patent Pool and Novartis announced on the last day of the World Cancer Congress an agreement for the first voluntary licensing of a cancer medicine, nilotinib.
UICC is looking forward to welcoming delegates and opening the World Cancer Congress next Tuesday on 18 October.
At today’s General Assembly, UICC full members welcomed the new President, Prof. Jeff Dunn AO, and voted for the 2022-2024 Board of Directors, including the new President-elect, Ulrika Årehed Kågström.
The winners of UICC’s Best CEO and Best World Cancer Day Campaign Awards were announced today at UICC’s General Assembly.
At UE LifeSciences, we believe that early detection of cancer must be affordable, equitable and accessible to all. We’re an award-winning women’s health company that is developing and scaling innovative solutions to fight common cancers in women globally. Our non-invasive and easy to use hand-held tools enable healthcare providers to bring early detection of breast and cervical cancer to the women in their community, where they live and work. Our innovation has received Innovative Health Technology recognition from the World Health Organization and Global Women’s HealthTech Award from the World Bank in 2022. With headquarters in the United States, UE LifeSciences has presence in India and Malaysia.
For International Breast Cancer Awareness Month, Cheri Ambrose has been invited to share some facts and figures about breast cancer in men.
Prof. Anil D’Cruz presided during two unique years in UICC’s history, as the world was gripped by a global pandemic, in-person meetings were cancelled and the cancer community showed extraordinary courage and resilience.
